-
Regulatory limbo: the case of NAC
13 April 2023
The more effective a natural product, the greater the risk if it sits in an uncertain, regulatory ‘no man’s land’
-
Pathfinder Members' Briefing and Q&A - April 2023
20 April 2023
Zoom recording of our Pathfinder members' briefing and Q&A for April 2023
-
Pathfinder Members' Briefing and Q&A - April 2023
20 April 2023
Zoom recording of our Pathfinder members' briefing and Q&A for April 2023
-
FEATURE: Frequency Medicine (Part 2) - Devices: Wacky or Worthy?
01 February 2023
Rob Verkerk PhD’s second part of his evaluation of frequency medicine, this time diving deep into devices that measure or deliver frequencies to the body
-
Pathfinder Members' Briefing and Q&A - January 2023
19 January 2023
Zoom recording of our Pathfinder members' briefing and Q&A for January 2023
-
Pathfinder Members' Briefing and Q&A - January 2023
19 January 2023
Zoom recording of our Pathfinder members' briefing and Q&A for January 2023
-
Therapeutic vitamins at risk from Brussels
12 October 2022
ANH Europe launched via webinar along with opening campaign on putting benefit back into safety assessment of therapeutic food supplements
-
Pathfinder Members' Briefing and Q&A - October 2022
20 October 2022
Zoom recording of our Pathfinder members' briefing and Q&A for October 2022
-
Pathfinder Members' Briefing and Q&A - September 2022
22 September 2022
Zoom recording of our Pathfinder members' briefing and Q&A for September 2022
-
Natural News Roundup (week 23/2022)
09 June 2022
EFSA stalls CBD novel food approval; New approach to healthy ageing needed; EFSA reviews copper ADI; Merck fights HPV lawsuit; Glyphosate damages gut microbiome; Mosquitoes learn to dodge pesticides; What we're reading